Who is sponsoring NCT01961466?

NCT01961466 is sponsored by Centre Hospitalier Universitaire Dijon.

What drugs are being tested in NCT01961466?

Interventions in NCT01961466: psychological and social self-administered questionnaires.

What condition does NCT01961466 study?

NCT01961466 studies Type 1 or 2 Diabetes.

Is NCT01961466 still recruiting?

NCT01961466 is currently completed. Last updated 4 September 2019.

Last reviewed 2019-09-04 · How we verify

NCT01961466: DPP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diabetes and Psychological Profile

Completed Last updated 4 September 2019

What this trial tests

trial testing psychological and social self-administered questionnaires in Type 1 or 2 Diabetes in 592 participants. Completed in 1 January 2015.

Timeline

1 December 2010

Primary endpoint
1 January 2015

1 January 2015

Quick facts

Lead sponsor	Centre Hospitalier Universitaire Dijon
Status	Completed
Study type	OBSERVATIONAL
Enrollment	592
Start date	1 December 2010
Primary completion	1 January 2015
Estimated completion	1 January 2015
Sites	1 location across France

Drugs / interventions tested

psychological and social self-administered questionnaires

Conditions studied

Type 1 or 2 Diabetes — all drugs for Type 1 or 2 Diabetes →

Sponsor

Centre Hospitalier Universitaire Dijon

Who can join

18 and older, any sex, with Type 1 or 2 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is based on the analysis of psychological and social questionnaires filled in by diabetic patients whose glycemic balance will be assessed by measuring blood levels of glycated haemoglobin. The aim is to compare glycemic balance by measuring HbA1c in diabetic patients (type 1 and 2) according to whether they have a Type A or B psychosomatic profile evaluated by the Bortner self-questionnaire.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Personality types in individuals with type 1 and type 2 diabetes.
Rouland A, Chauvet-Gelinier JC, Sberna AL, Crevisy E, et al · · 2020 · cited 4× · PMID 32101526 · DOI 10.1530/ec-19-0499

Verify or expand the search:

Other Centre Hospitalier Universitaire Dijon trials

Trials by the same sponsor.

NCT06608004 — Influence of Olfacto-gustatory Sensoriality on the Nutritional Status of Patients With Amyotrophic Lateral Sclerosis · recruiting
NCT07432789 — Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performa · NA · recruiting
NCT06776848 — A Pilot, Multicentre, Controlled, Open-label Study Evaluating 24 Months of Lithium Carbonate Treatment in Patients With · Phase 1, PHASE2 · recruiting
NCT06347302 — Study of Vitreoretinal Molecular Changes During Rhegmatogenous Retinal Detachment · NA · completed
NCT06252415 — Evaluation of Rapid First-line Genome Sequencing for Prenatal Diagnosis of Congenital Malformations in Comparison With C · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01961466 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire Dijon
Last refreshed: 4 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01961466.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing